Категорія
Гео і мова каналу
всі пости Dr. Lynn Fynn’s Science Enlightenment Channel & Stuff
Evidence based analysis of mainstream scientific inaccuracies- Not medical advice
TWITTER f https://mobile.twitter.com/fynn_fan
https://americasfrontlinedoctors.org/2/authors/dr-lynn-fynn/
https://bluntforcetruth.com/covid-truths-from-real-doctors-ep
33 507-24
~12 842
~16
36.41%
Архів постів
Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan
During the COVID-19 pandemic, excess deaths including cancer have become a concern in Japan, which has a rapidly aging population. Thus, this study aimed to evaluate how age-adjusted mortality r...
Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer? - PubMed
Due to the health emergency created by SARS-CoV-2, the virus that causes the COVID-19 disease, the rapid implementation of a new vaccine technology was necessary. mRNA vaccines, being one of the cutting-edge new technologies, attracted significant interest and offered a lot of hope. The potential of …
The Doctor Will Ask About Your Gun Now
More physicians are making gun safety part of routine visits. But should they be?
Study links long-term consumption of deep-fried oil with increased neurodegeneration
Animal study suggests deep-fried oil disrupts liver-gut-brain connections.
Persistence of S1 Spike Protein in CD16+ Monocytes up to 245 Days in SARS-CoV-2 Negative Post COVID-19 Vaccination Individuals with Post-Acute Sequalae of COVID-19 (PASC)-Like Symptoms
There have been concerning reports about people experiencing new onset persistent complications (greater than 30 days) following approved SARS-CoV-2 vaccines (BNT162b2 (Pfizer), mRNA-1273 (Moderna), Janssen (Johnson and Johnson), and ChAdOx1 nCoV-19 (AstraZeneca)). We sought to determine the immunologic abnormalities in these patients and to investigate whether the potential etiology was similar to Post-Acute Sequalae of COVID (PASC), or long COVID. We studied 50 individuals who received one of the approved COVID-19 vaccines and who experienced new onset PASC-like symptoms along with 45 individuals post-vaccination without symptoms as controls. We performed multiplex cytokine/chemokine profiling with machine learning as well as SARS-CoV-2 S1 protein detection on CD16+ monocyte subsets using flow cytometry and mass spectrometry. We determined that post-vaccination individuals with PASC-like symptoms had similar symptoms to PASC patients. When analyzing their immune profile, Post-vaccination individuals had statistically…